Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- Sponsors Allergan
- 18 Jan 2018 Status changed from active, no longer recruiting to completed.
- 11 Sep 2017 Planned End Date changed from 1 May 2018 to 11 Nov 2017.
- 11 Sep 2017 Status changed from recruiting to active, no longer recruiting.